Authors' Response to: Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial

We appreciate the comments from Kako and colleagues. At this time, there is still a paucity of literature to inform the opioid of choice for management of dyspnea. To our knowledge, randomized trials examining the prophylactic use of opioids for episodic dyspnea in cancer patients to date have only involved fentanyl.1-5 No head-to-head comparison of opioids has been conducted for this indication.
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Tags: Letter Source Type: research